Sun Pharma’s focus on specialty drugs pays off
The company’s revenues grew 11% driven by strong growth posted by the India business and the global specialty sales in the US. A third of the company’s revenues is earned each from India and the US. Sun’s market share in India increased from 8.3% to 8.4% for the year ended September 2023.
View: Privacy rules around credit information companies need tightening
The volume of data that flows into a CIC is humongous. All the CICs are expected to receive credit information from all CIs as per RBI stipulations. However, gaps seem to exist in reporting and in ensuring that the information is accurate, which results in inaccurate credit scores in some cases.
IDBI Bank moves to sell Rs 8,843 crore of bad loans
The assets on the block are a dozen cases including loans to Videocon Oil Ventures (VOVL), Jaiprakash Associates (JAL) and Wind World, which are facing various delays in their resolution.
Federal Reserve leaves interest rates unchanged
“Economic activity expanded at a strong pace in the third quarter,” the US central bank said in a policy statement after a two-day meeting in which officials unanimously agreed to leave the benchmark overnight interest rate in the 5.25-5.50% range where it has been since July.